Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping-Reference-Cited by-同舟云学术

Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping

Published:2012-06-27 Issue:2 Volume:92 Page:235-242
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Schildcrout J S,Denny J C,Bowton E,Gregg W,Pulley J M,Basford M A,Cowan J D,Xu H,Ramirez A H,Crawford D C,Ritchie M D,Peterson J F,Masys D R,Wilke R A,Roden D M

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. Pharmacogenetics and Pharmacogenomics: Development, Science, and Translation

2. Pharmacogenomics at the Tipping Point: Challenges and Opportunities

3. Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use

4. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA

5. The Path to Personalized Medicine

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care;The Pharmacogenomics Journal;2024-03-15

2. Estimation of the benefit from pre‐emptive genotyping based on the nationwide cohort data in South Korea;Clinical and Translational Science;2024-03

3. Trends and implementation of preemptive pharmacogenomic testing;Comprehensive Precision Medicine;2024

4. Cardiovascular pharmacogenomics – Molecular basis of protective and adverse drug response;Genomic and Molecular Cardiovascular Medicine;2024

5. Implementing preemptive, multigene, pharmacogenomic testing in the inpatient setting: Preliminary results from a small, rural facility;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-12-28